Synthesis and evaluation of novel Tc-99m labeled probestin conjugates for imaging APN/CD13 expression in vivo

Bioconjugate Chemistry

Volumn 23, Issue 1, 2012, Pages 115-124

  Pathuri, Gopal ^a   Hedrick, Andria F ^a   Disch, Bryan C ^a   Doan, John T ^b   Ihnat, Michael A ^a,c   Awasthi, Vibhudutta ^a   Gali, Hariprasad ^a,c  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF PHARMACY   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOACTIVITY; ENZYME ACTIVITY; ENZYME INHIBITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; RHENIUM COMPOUNDS; SPECTRUM ANALYSIS; TUMORS;

AMINO PEPTIDASE; ANGIOGENESIS; HIGH AFFINITY; HT-1080 CELLS; IN-VIVO; POST INJECTION; SYNTHESIS EVALUATION; TUMOR INVASION; TUMOR PROLIFERATION; WHOLE-BODY;

SYNTHESIS (CHEMICAL);

MICROSOMAL AMINOPEPTIDASE; PROBESTIN; RHENIUM; TECHNETIUM 99M;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DRUG CONJUGATION; DRUG DISTRIBUTION; DRUG SYNTHESIS; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; HUMAN; HUMAN CELL; ISOTOPE LABELING; MOUSE; NONHUMAN; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; TISSUE DISTRIBUTION; TUMOR XENOGRAFT;

MUS MUSCULUS;

EID: 84855945629     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc200546b     Document Type: Article

References (66)

1. Look, A. T., Ashmun, R. A., Shapiro, L. H., and Peiper, S. C. (1989) Human myeloid plasma membrane glycoprotein CD13 (gp150) is identical to aminopeptidase N J. Clin. Invest. 83, 1299-307 (Pubitemid 19113045)
2. Sjostrom, H., Noren, O., and Olsen, J. (2000) Structure and function of aminopeptidase N Adv. Exp. Med. Biol. 477, 25-34 (Pubitemid 32173986)
3. Shipp, M. and Look, A. (1993) Hematopoietic differentiation antigens that are membrane-associated enzymes: cutting is the key! Blood 82, 1052-1070 (Pubitemid 23253976)
4. Dixon, J., Kaklamanis, L., Turley, H., Hickson, I. D., Leek, R. D., Harris, A. L., and Gatter, K. C. (1994) Expression of aminopeptidase-n (CD 13) in normal tissues and malignant neoplasms of epithelial and lymphoid origin J. Clin. Pathol. 47, 43-47 (Pubitemid 24057748)
5. Kenny, A. J. and Maroux, S. (1982) Topology of microvillar membrance hydrolases of kidney and intestine Physiol. Rev. 62, 91-128
6. Tokuhara, T., Hattori, N., Ishida, H., Hirai, T., Higashiyama, M., Kodama, K., and Miyake, M. (2006) Clinical significance of aminopeptidase N in non-small cell lung cancer Clin. Cancer Res. 12, 3971-8 (Pubitemid 44078082)
7. Hashida, H., Takabayashi, A., Kanai, M., Adachi, M., Kondo, K., Kohno, N., Yamaoka, Y., and Miyake, M. (2002) Aminopeptidase N is involved in cell motility and angiogenesis: its clinical significance in human colon cancer Gastroenterology 122, 376-86 (Pubitemid 34116989)
8. Ishii, K., Usui, S., Sugimura, Y., Yoshida, S., Hioki, T., Tatematsu, M., Yamamoto, H., and Hirano, K. (2001) Aminopeptidase N regulated by zinc in human prostate participates in tumor cell invasion Int. J. Cancer 92, 49-54 (Pubitemid 32187031)
9. Wickström, M., Larsson, R., Nygren, P., and Gullbo, J. (2011) Aminopeptidase N (CD13) as a target for cancer chemotherapy Cancer Sci. 102, 501-508
10. Menrad, A., Speicher, D., Wacker, J., and Herlyn, M. (1993) Biochemical and functional characterization of aminopeptidase N expressed by human melanoma cells Cancer Res. 53, 1450-1455 (Pubitemid 23097131)
11. Saiki, I., Yoneda, J., Azuma, I., Fujii, H., Abe, F., Nakajima, M., and Tsuruo, T. (1993) Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradation Int. J. Cancer 54, 137-143 (Pubitemid 23137011)
12. Fujii, H., Nakajima, M., Saiki, I., Yoneda, J., Azuma, I., and Tsuruo, T. (1995) Human melanoma invasion and metastasis enhancement by high expression of aminopeptidase N/CD13 Clin. Exp. Metastasis 13, 337-344
13. Pasqualini, R., Koivunen, E., Kain, R., Lahdenranta, J., Sakamoto, M., Stryhn, A., Ashmun, R. A., Shapiro, L. H., Arap, W., and Ruoslahti, E. (2000) Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis Cancer Res. 60, 722-7 (Pubitemid 30094573)
14. Bhagwat, S. V., Lahdenranta, J., Giordano, R., Arap, W., Pasqualini, R., and Shapiro, L. H. (2001) CD13/APN is activated by angiogenic signals and is essential for capillary tube formation Blood 97, 652-659 (Pubitemid 32113397)
15. Zhang, Z., Hatta, H., Ito, T., and Nishimoto, S. (2005) Synthesis and photochemical properties of photoactivated antitumor prodrugs releasing 5-fluorouracil Org. Biomol. Chem. 3, 592-6 (Pubitemid 40296611)
16. Ndinguri, M. W., Solipuram, R., Gambrell, R. P., Aggarwal, S., and Hammer, R. P. (2009) Peptide targeting of platinum anti-cancer drugs Bioconjugate Chem. 20, 1869-1878
17. van Laarhoven, H. W., Gambarota, G., Heerschap, A., Lok, J., Verhagen, I., Corti, A., Toma, S., Gallo Stampino, C., van der Kogel, A., and Punt, C. J. (2006) Effects of the tumor vasculature targeting agent NGR-TNF on the tumor microenvironment in murine lymphomas Invest. New Drugs 24, 27-36 (Pubitemid 43163422)
18. Zhang, Z., Harada, H., Tanabe, K., Hatta, H., Hiraoka, M., and Nishimoto, S. (2005) Aminopeptidase N/CD13 targeting fluorescent probes: synthesis and application to tumor cell imaging Peptides 26, 2182-7 (Pubitemid 41584082)
19. Moffatt, S., Wiehle, S., and Cristiano, R. J. (2005) Tumor-specific gene delivery mediated by a novel peptide-polyethylenimine-DNA polyplex targeting aminopeptidase N/CD13 Hum. Gene Ther. 16, 57-67 (Pubitemid 40250332)
20. van Hensbergen, Y., Broxterman, H. J., Elderkamp, Y. W., Lankelma, J., Beers, J. C., Heijn, M., Boven, E., Hoekman, K., and Pinedo, H. M. (2002) A doxorubicin-CNGRC-peptide conjugate with prodrug properties Biochem. Pharmacol. 63, 897-908 (Pubitemid 34243003)
21. Curnis, F., Sacchi, A., Borgna, L., Magni, F., Gasparri, A., and Corti, A. (2000) Enhancement of tumor necrosis factor alpha antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13) Nat. Biotechnol. 18, 1185-90
22. Arap, W., Pasqualini, R., and Ruoslahti, E. (1998) Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model Science 279, 377-80 (Pubitemid 28063372)
23. Zhang, Z., Hatta, H., Tanabe, K., and Nishimoto, S. (2005) A new class of 5-fluoro-2′-deoxyuridine prodrugs conjugated with a tumor-homing cyclic peptide CNGRC by ester linkers: synthesis, reactivity, and tumor-cell-selective cytotoxicity Pharm. Res. 22, 381-9 (Pubitemid 40558496)
24. von Wallbrunn, A., Waldeck, J., Holtke, C., Zuhlsdorf, M., Mesters, R., Heindel, W., Schafers, M., and Bremer, C. (2008) In vivo optical imaging of CD13/APN-expression in tumor xenografts J. Biomed. Opt. 13, 011007
25. Oostendorp, M., Douma, K., Hackeng, T. M., Dirksen, A., Post, M. J., van Zandvoort, M. A. M. J., and Backes, W. H. (2008) Quantitative molecular magnetic resonance imaging of tumor angiogenesis using cNGR-labeled paramagnetic quantum dots Cancer Res. 68, 7676-7683
26. Ellerby, H. M., Bredesen, D. E., Fujimura, S., and John, V. (2008) Hunter-killer peptide (HKP) for targeted therapy J. Med. Chem. 51, 5887-5892
27. Gregorc, V., Zucali, P. A., Santoro, A., Ceresoli, G. L., Citterio, G., De Pas, T. M., Zilembo, N., De Vincenzo, F., Simonelli, M., Rossoni, G., Spreafico, A., Grazia Vigano, M., Fontana, F., De Braud, F. G., Bajetta, E., Caligaris-Cappio, F., Bruzzi, P., Lambiase, A., and Bordignon, C. (2010) Phase II study of asparagine-glycine-arginine-human tumor necrosis factor {alpha}, a selective vascular targeting agent, in previously treated patients with malignant pleural mesothelioma J. Clin. Oncol. 28, 2604-2611
28. Curnis, F., Longhi, R., Crippa, L., Cattaneo, A., Dondossola, E., Bachi, A., and Corti, A. (2006) Spontaneous formation of L-isoaspartate and gain of function in fibronectin J. Biol. Chem. 281, 36466-36476 (Pubitemid 46041380)
29. Curnis, F., Sacchi, A., Gasparri, A., Longhi, R., Bachi, A., Doglioni, C., Bordignon, C., Traversari, C., Rizzardi, G.-P., and Corti, A. (2008) Isoaspartate-glycine-arginine: a new tumor vasculature-targeting motif Cancer Res. 68, 7073-7082
30. Spitaleri, A., Mari, S., Curnis, F., Traversari, C., Longhi, R., Bordignon, C., Corti, A., Rizzardi, G.-P., and Musco, G. (2008) Structural basis for the interaction of isoDGR with the RGD-binding site of {alpha}v{beta}3 integrin J. Biol. Chem. 283, 19757-19768
31. Curnis, F., Cattaneo, A., Longhi, R., Sacchi, A., Gasparri, A. M., Pastorino, F., Di Matteo, P., Traversari, C., Bachi, A., Ponzoni, M., Rizzardi, G.-P., and Corti, A. (2010) Critical role of flanking residues in NGR-to-isoDGR transition and CD13/Integrin receptor switching J. Biol. Chem. 285, 9114-9123
32. Corti, A., Curnis, F., Arap, W., and Pasqualini, R. (2008) The neovasculature homing motif NGR: more than meets the eye Blood 112, 2628-2635
33. Pathuri, G., Sahoo, K., Awasthi, V., and Gali, H. (2010) Synthesis and in vivo evaluation of Tc-99m-labeled cyclic CisoDGRC peptide conjugates for targeting [alpha]v[beta]3 integrin expression Bioorg. Med. Chem. Lett. 20, 5969-5972
34. Plesniak, L. A., Salzameda, B., Hinderberger, H., Regan, E., Kahn, J., Mills, S. A., Teriete, P., Yao, Y., Jennings, P., Marassi, F., and Adams, J. A. (2010) Structure and activity of CPNGRC: a modified CD13/APN peptidic homing motif Chem. Biol. Drug Des. 75, 551-562
35. Aoyagi, T., Yoshida, S., Nakamura, Y., Shigihara, Y., Hamada, M., and Takeuchi, T. (1990) Probestin, a new inhibitor of aminopeptidase M, produced by Streptomyces azureus MH663-2F6. I. Taxonomy, production, isolation, physico-chemical properties and biological activities J. Antibiot. (Tokyo) 43, 143-8 (Pubitemid 20069961)
36. Itoh, Y., Ishikawa, M., Naito, M., and Hashimoto, Y. (2010) Protein knockdown using methyl bestatin-ligand hybrid molecules: design and synthesis of inducers of ubiquitination-mediated degradation of cellular retinoic acid-binding proteins J. Am. Chem. Soc. 132, 5820-5826
37. Noll, B., Kniess, T., Friebe, M., Spies, H., and Johannsen, B. (1996) Rhenium(V) gluconate, a suitable precursor for the preparation of rhenium(V) complexes Isotopes in Environmental and Health Studies 32, 21-29 (Pubitemid 126520088)
38. Smith, C. J., Gali, H., Sieckman, G. L., Higginbotham, C., Volkert, W. A., and Hoffman, T. J. (2003) Radiochemical investigations of (99m)Tc-N(3)S-X-BBN[7-14]NH(2): an in vitro/in vivo structure-activity relationship study where X = 0-, 3-, 5-, 8-, and 11-carbon tethering moieties Bioconjugate Chem. 14, 93-102 (Pubitemid 36169022)
39. Ashmun, R. and Look, A. (1990) Metalloprotease activity of CD13/aminopeptidase N on the surface of human myeloid cells Blood 75, 462-469 (Pubitemid 20035279)
40. Folkman, J. (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease Nat. Med. 1, 27-31
41. Hanahan, D. and Folkman, J. (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis Cell 86, 353-64 (Pubitemid 26272076)
42. Plate, K. H., Breier, G., and Risau, W. (1994) Molecular mechanisms of developmental and tumor angiogenesis Brain Pathol. 4, 207-18 (Pubitemid 24261926)
43. Folkman, J. (1971) Tumor angiogenesis: therapeutic implications N. Engl. J. Med. 285, 1182-6
44. Folkman, J. (2007) Angiogenesis: an organizing principle for drug discovery? Nat. Rev. Drug Discovery 6, 273-286 (Pubitemid 46505878)
45. Beer, A. J., Wester, H.-J., and Schwaiger, M. (2010) Molecular Imaging of Angiogenesis 105-115
46. Hsu, A. R. and Chen, X. (2008) Advances in anatomic, functional, and molecular imaging of angiogenesis J. Nucl. Med. 49, 511-514 (Pubitemid 351520621)
47. Kenny, L. M., Coombes, R. C., Oulie, I., Contractor, K. B., Miller, M., Spinks, T. J., McParland, B., Cohen, P. S., Hui, A.-M., Palmieri, C., Osman, S., Glaser, M., Turton, D., Al-Nahhas, A., and Aboagye, E. O. (2008) Phase I trial of the positron-emitting Arg-Gly-Asp (RGD) peptide radioligand 18F-AH111585 in breast cancer patients J. Nucl. Med. 49, 879-886 (Pubitemid 351793427)
48. Bach-Gansmo, T., Danielsson, R., Saracco, A., Wilczek, B., Bogsrud, T. V., Fangberget, A., Tangerud, A., and Tobin, D. (2006) Integrin receptor imaging of breast cancer: a proof-of-concept study to evaluate 99mTc-NC100692 J. Nucl. Med. 47, 1434-9 (Pubitemid 47544928)
49. Beer, A. J., Niemeyer, M., Carlsen, J., Sarbia, M., Nahrig, J., Watzlowik, P., Wester, H.-J., Harbeck, N., and Schwaiger, M. (2008) Patterns of {alpha}v{beta}3 expression in primary and metastatic human breast cancer as shown by 18F-Galacto-RGD PET J. Nucl. Med. 49, 255-259 (Pubitemid 351225664)
50. Mittra, E. S., Goris, M. L., Iagaru, A. H., Kardan, A., Burton, L., Berganos, R., Chang, E., Liu, S., Shen, B., Chin, F. T., Chen, X., and Gambhir, S. S. (2011) Pilot pharmacokinetic and dosimetric studies of (18)F-FPPRGD2: a PET radiopharmaceutical agent for imaging alpha(v)beta(3) integrin levels Radiology 260, 182-91
51. Arano, Y. (2002) Recent advances in Tc-99m radiopharmaceuticals Ann. Nucl. Med. 16, 79-93
52. Jurisson, S. S. and Lydon, J. D. (1999) Potential technetium small molecule radiopharmaceuticals Chem. Rev. 99, 2205-2218
53. Bartholoma, M. D., Louie, A. S., Valliant, J. F., and Zubieta, J. (2010) Technetium and gallium derived radiopharmaceuticals: comparing and contrasting the chemistry of two important radiometals for the molecular imaging era Chem. Rev. 110, 2903-2920
54. Francesconi, L. C., Zheng, Y., Bartis, J., Blumenstein, M., Costello, C., and De Rosch, M. A. (2004) Preparation and characterization of [99TcO] apcitide: a technetium labeled peptide Inorg. Chem. 43, 2867-2875
55. Cyr, J. E., Pearson, D. A., Nelson, C. A., Lyons, B. A., Zheng, Y., Bartis, J., He, J., Cantorias, M. V., Howell, R. C., and Francesconi, L. C. (2007) Isolation, characterization, and biological evaluation of syn and anti diastereomers of [99mTc]technetium depreotide: a somatostatin receptor binding tumor imaging agent J. Med. Chem. 50, 4295-4303 (Pubitemid 47378829)
56. Cantorias, M. V., Howell, R. C., Todaro, L., Cyr, J. E., Berndorff, D., Rogers, R. D., and Francesconi, L. C. (2007) MO tripeptide diastereomers (M = 99/99mTc, Re): models to identify the structure of 99mTc peptide targeted radiopharmaceuticals Inorg. Chem. 46, 7326-7340
57. Wong, E., Fauconnier, T., Bennett, S., Valliant, J., Nguyen, T., Lau, F., Lu, L. F. L., Pollak, A., Bell, R. A., and Thornback, J. R. (1997) Rhenium(V) and technetium(V) oxo complexes of an N2NS peptidic chelator: evidence of interconversion between the syn and anti conformations Inorg. Chem. 36, 5799-5808 (Pubitemid 127483497)
58. Francesconi, L. C., Graczyk, G., Wehrli, S., Shaikh, S. N., McClinton, D., Liu, S., Zubieta, J., and Kung, H. F. (1993) Synthesis and characterization of neutral MVO (M = technetium, rhenium) amine-thiol complexes containing a pendant phenylpiperidine group Inorg. Chem. 32, 3114-3124
59. Lever, S. Z., Baidoo, K. E., and Mahmood, A. (1990) Structure proof of syn/anti isomerism in N-alkylated diaminedithiol (DADT) complexes of technetium Inorg. Chim. Acta 176, 183-184
60. Valliant, J. F., Riddoch, R. W., Hughes, D. W., Roe, D. G., Fauconnier, T. K., and Thornback, J. R. (2001) The solid phase synthesis and NMR spectroscopy of a 99Tc chelate-bombesin derived peptide conjugate Inorg. Chim. Acta 325, 155-163 (Pubitemid 33092091)
61. Wong, E., Bennett, S., Lawrence, B., Fauconnier, T., Lu, L. F. L., Bell, R. A., Thornback, J. R., and Eshima, D. (2001) Tuftsin receptor-binding peptide labeled with technetium: chemistry and preliminary in vitro receptor-binding study Inorg. Chem. 40, 5695-5700 (Pubitemid 33009293)
62. Bauvois, B. and Dauzonne, D. (2006) Aminopeptidase-N/CD13 (EC 3.4.11.2) inhibitors: chemistry, biological evaluations, and therapeutic prospects Med. Res. Rev. 26, 88-130 (Pubitemid 43986471)
63. Stange, T., Kettmann, U., and Holzhausen, H. J. (1996) Immunoelectron microscopic single and double labelling of aminopeptidase N (CD 13) and dipeptidyl peptidase IV (CD 26) Acta Histochem. 98, 323-31 (Pubitemid 26291891)
64. Li, Z.-b., Cai, W., Cao, Q., Chen, K., Wu, Z., He, L., and Chen, X. (2007) 64Cu-labeled tetrameric and octameric RGD peptides for small-animal PET of tumor {alpha}v{beta}3 integrin expression J. Nucl. Med. 48, 1162-1171 (Pubitemid 47052657)
65. Liu, S. (2009) Radiolabeled cyclic RGD peptides as integrin αvβ3-targeted radiotracers: maximizing binding affinity via bivalency Bioconjugate Chem. 20, 2199-2213
66. Mammen, M., Choi, S. K., and Whitesides, G. M. (1998) Polyvalent interactions in biological systems: Implications for design and use of multivalent ligands and inhibitors Angew. Chem., Int. Ed. 37, 2755-2794